newsfilter
← Latest News
GlobeNewswire·

Athenex, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Warrants

BUFFALO, N.Y., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. ("Athenex") (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related cond